RxDoctor Payments Data

Brendon Coughtry, MD

Interventional Pain Medicine · Campbellsville, KYNPI 1669514840

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.2% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Abbott at 25.2% of the total. Reporting peaked in 2022 at $1,141 and has fallen 92.5% since, to $86 in 2025.

$4,095in general payments, 2019–2025

Across 244 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • AbbVie$757
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$508
  • Amgen$371
  • Nevro Corp.$215
  • Daiichi Sankyo Inc.$199
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,98097%
  • Education$1153%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,095 in reported general payments places this provider in the 55th percentile of 55 interventional pain medicine providers in Kentucky.

See all interventional pain medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$361,077
Medicare patients
646
Services billed
7,782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen4,368$77,757
PercocetOxycodone Hcl/Acetaminophen16$54,671
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,985$44,464
Oxycodone Hcl475$9,349
Gabapentin427$3,677
Fentanyl21$2,988
AmantadineAmantadine Hcl17$2,183
Pregabalin97$1,775
Morphine Sulfate ErMorphine Sulfate34$882
Methadone Hcl46$818
Hydromorphone Hcl36$616
Meloxicam21$529
Morphine Sulfate16$522
Acetaminophen-CodeineAcetaminophen With Codeine32$497
EndocetOxycodone Hcl/Acetaminophen19$462

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Campbellsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →